Zydus Lifesciences Ltd.

Cadila Healthcare has informed that a meeting of Audit Committee and the Board of Directors of the Company will be held on April 22, 2013 to consider a proposal for exploring the possibilities for merger of certain wholly owned subsidiary companies with the Company and to approve the draft Scheme of Amalgamation under Section 391-394 of the Companies Act, 1956.

The above information is a part of company’s filings submitted to BSE.